The Law Firm of Arons & Arons, LLC. has initiated an investigation of Intercept Pharmaceuticals Inc. (“Intercept” or the “Company”) (NASDAQ:ICPT) on behalf of the company’s investors for possible violations of federal securities law.

Intercept investors who would like to discuss this investigation and their legal options should contact Arons & Arons, LLC. (Jeffrey S. Arons, Esq.) at (973) 762-0795, (877) 512-7667 or email us at info@aronslaw.net. For more information please visit https://www.aronslaw.net/investigations

According to a report issued by Bloomberg, Intercept Pharmaceuticals, Inc. dropped to its lowest price since 2013 today after analysts cut their price targets for the shares. This occurred following reports of additional patient deaths and a warning by the U.S. Food and Drug Administration. On Thursday, the FDA said it has identified 19 deaths of people on the Intercept’s drug, Ocaliva and that the drug may also be associated with liver in injury in some patients with mild diseases who are receiving the correct dose. The company’s stock fell as much as 17 percent on Friday, after dropping 25 percent the day before. Analysts are now calling into question the credibility of Intercept’s management after FDA’s safety announcement raised concerns beyond what was mentioned in a letter the Company sent to doctors the previous week.

If you are an investor in Intercept, or have information pertaining to this investigation, you are encouraged to contact Arons & Arons, LLC. (Jeffrey Arons, Esq.) at (973) 762-0795, (877) 512-7667 or email us at info@aronslaw.net. For more information please visit https://www.aronslaw.net/investigations

Arons & Arons, LLC. is a family oriented firm, that provides representation for individuals, including investors who have been victimized by securities fraud. Our attorneys understand the financial and emotional trauma that securities fraud can cause, and we are relentless in our efforts to hold corporate wrongdoers accountable and obtain compensation for our clients. For over 30 years our attorneys have provided personal, accessible, and effective legal representation for our clients. www.aronslaw.net

This press release may be considered Attorney Advertising in some jurisdictions under applicable laws and ethical rules.

Arons & Arons, LLC.Jeffrey Arons, Esq.973-762-0795877-512-7667info@aronslaw.net

Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Intercept Pharmaceuticals Charts.
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Intercept Pharmaceuticals Charts.